Related Experiment Video

Updated: Aug 20, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Stem cells and myocardial regeneration

Teresa Pinto-Almeida1, Tiago Henriques-Coelho, José S Fortunato

  • 1Serviço de Fisiologia da Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|December 14, 2004
PubMed

Insights

Stem cells (SCs) can regenerate heart cells, challenging the idea that the heart is a post-mitotic organ. Cellular cardiomyoplasty (CCM) using SCs shows promise for treating cardiac diseases.

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • The heart was traditionally considered a post-mitotic organ, incapable of significant regeneration.
  • Recent discoveries show that differentiated cells, including cardiomyocytes, can be regenerated by stem cells (SCs).
  • This challenges the long-held dogma regarding cardiac repair limitations.

Purpose of the Study:

  • To review the different types of stem cells (SCs) investigated for cardiac repair.
  • To discuss the advantages and limitations of various SC types in the context of heart disease.
  • To explore the potential therapeutic applications of SC-based strategies like cellular cardiomyoplasty (CCM).

Main Methods:

  • Review of experimental models for stem cell transplantation into damaged myocardium.
  • Analysis of studies investigating cardiac SC differentiation and bone marrow SCs for cardiac regeneration.
  • Evaluation of cellular cardiomyoplasty (CCM) strategies.

Main Results:

  • Stem cells (SCs) demonstrate the capacity for cardiomyocyte renewal, challenging the post-mitotic heart dogma.
  • Various SC types have been explored in experimental models for transplantation into damaged hearts.
  • Cellular cardiomyoplasty (CCM) shows potential benefits for improving cardiac function.

Conclusions:

  • Stem cell research is reshaping the understanding of cardiac regenerative capacity.
  • Cellular cardiomyoplasty (CCM) offers a promising therapeutic avenue for cardiac diseases.
  • Further research is needed to address remaining questions regarding SC efficacy and safety in cardiac repair.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...